Healthcare and Life Science
Cambridge VC investment surges to $2.3 billion as science-led innovation abounds
Cambridge startups and scaleups raised an impressive $2.3 billion in 2024, the second-best year on record and almost double 2023’s $1.2 billion. ...
Xampla’s plant protein microcapsules spotlighted in Royal Society of Chemistry journal
New peer-reviewed research in the Royal Society of Chemistry journal Sustainable Food Technology, shows Xampla’s novel plant protein microcapsules retain oil-based activities through simulated digestion, all the way to the intestinal phase. ...
Astoriom expands global footprint for sample stability storage services
Growth in dedicated sample stability facilities at Tramore (Ireland) site to meet demand for flexible, regulatory-compliant storage solutions ...
Closed Loop Medicine appoints Kate Woolland as CEO
Leadership transition to drive commercialization strategy in deploying and scaling proven platform and therapy-specific precision dosing technologies ...
The strategic importance of private 5G networks
In the rapidly evolving landscape of emergency response, connectivity, reliability, and security are paramount. Private 5G networks are emerging as a transformative force, providing first responders across the United States with unprecedented communication capabilities. ...
Cooling for Aesthetic Laser Systems: Meeting Huge Demands with Compact Solutions
Small and compact laser systems have become a staple of the growing aesthetics market – mostly for skin treatments like hair removal. To offer a well-balanced system, manufacturers must balance several conflicting factors. This results in high demands towards the system components. ...
Efficient Subcontracting in Europe: Expanding HMLV Capabilities
In today's dynamic business environment, companies are increasingly turning to subcontracting as a strategic approach to manage high-mix, low-volume (HMLV) production ...
CN Bio expands access to OOC solutions for APAC customers with distributor agreement in South Korea
Partnership with SCINCO strengthens international sales and technical support channels in key region as part of ongoing global expansion ...
Shift Bioscience appoints Lord David Prior and Sir Tony Kouzarides to support long-term strategy for cell rejuvenation therapeutics
Lord David Prior appointed as Chair of the Board, previously Chairman of NHS England and member of the UK Life Sciences Council Sir Tony Kouzarides, Co-founder and Director, Milner Therapeutics Institute, and Professor of Cancer Biology, Gurdon Institute, appointed as Scientific Advisor...
Why SMEs are rethinking their marketing strategy to grow in 2025
The marketing landscape has changed significantly in the past two years, and many SMEs are beginning to take notice. For start-ups and growing businesses focused on R&D, strategy, or business development, marketing can often feel like an afterthought. Yet in today’s digital economy,...